TrialThe Journal of clinical endocrinology and metabolism2024

Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine.

Mônica R Gadelha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.